Publications by authors named "Ken-Ichi Tani"

Article Synopsis
  • VT non-inducibility after radiofrequency (RF) ablation is generally linked to a lower chance of ventricular tachycardia (VT) recurrence, but its routine use as an endpoint is debated.
  • A study analyzed 62 patients who did not achieve VT non-inducibility post-ablation, finding that 35% experienced VT recurrences over two years.
  • Key factors influencing lower VT recurrence included a left ventricular ejection fraction (LVEF) of 35% or higher and the successful elimination of clinical VT during the procedure.
View Article and Find Full Text PDF

Background: Lesion gaps assessed by late-gadolinium enhancement magnetic resonance imaging (LGE-MRI) are associated with the atrial fibrillation (AF) recurrence after pulmonary vein isolation. Animal studies have demonstrated that the catheter-contact force (CF), stability, and orientation are strongly associated with lesion formation. However, the impact of those procedural factors on the lesion characteristics associated with AF recurrence has not been well discussed.

View Article and Find Full Text PDF

Background: It is uncertain whether cardiac resynchronization therapy with a defibrillator (CRT-D) provides better survival benefits than a CRT-pacemaker (CRT-P) in heart failure patients with a reduced ejection fraction (≦35%, HFrEF) treated with contemporary HF therapy.

Methods: We retrospectively analyzed the ventricular arrhythmia (VAs; sustained ventricular tachycardia/fibrillation) events in HFrEF patients who underwent CRT without a prior history of VAs or aborted sudden cardiac death before the CRT implantation. Between January/2010 and December/2020, a CRT device was implanted in 79 HFrEF patients (mean age: 69 ± 12 years, male: 57, ischemic cardiomyopathy: 16).

View Article and Find Full Text PDF

Background: Corticosteroids are widely used in patients with cardiac sarcoidosis (CS). In addition, upgrading to cardiac resynchronization therapy (CRT) is sometimes needed. This study aimed to investigate the impact of corticosteroid use on the clinical outcomes following CRT upgrades.

View Article and Find Full Text PDF

Background: Some of atrial fibrillation (AF) drivers are found in normal/mild late-gadolinium enhancement (LGE) areas, as well as moderate ones. The atrial wall thickness (AWT) has been reported to be important as a possible AF substrate. However, the AWT and degree of LGEs as an AF substrate has not been fully validated in humans.

View Article and Find Full Text PDF